PAION AG Email Format

Pharmaceutical ManufacturingNorth Rhine-Westphalia, Germany11-50 Employees

PAION AG is a publicly listed specialty pharmaceutical company focused on hospital-based sedation, anesthesia and critical care. Its lead candidate, remimazolam, is an intravenous, ultra-short-acting benzodiazepine sedative and anesthetic, marketed in Europe as Byfavo and approved for procedural sedation in the U.S., EU/EEA/UK, China and South Korea, with additional approvals for general anesthesia in Japan and South Korea. Beyond remimazolam, PAION markets two intensive care medicines in select European markets: GIAPREZA (angiotensin II) for refractory hypotension in adults with septic or distributive shock, and XERAVA (eravacycline) for complicated intra-abdominal infections. The company is headquartered in Aachen, located in the North Rhine-Westphalia region of Germany, and operates within the pharmaceutical manufacturing sector.

Get verified PAION AG emails free

Company overview Employee directory